These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21384505)

  • 1. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.
    Salvalaggio PR; Dzebisashvili N; MacLeod KE; Lentine KL; Gheorghian A; Schnitzler MA; Hohmann S; Segev DL; Gentry SE; Axelrod DA
    Liver Transpl; 2011 Mar; 17(3):233-42. PubMed ID: 21384505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.
    Schaubel DE; Sima CS; Goodrich NP; Feng S; Merion RM
    Am J Transplant; 2008 Feb; 8(2):419-25. PubMed ID: 18190658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of center volume on outcomes of increased-risk liver transplants.
    Ozhathil DK; Li YF; Smith JK; Tseng JF; Saidi RF; Bozorgzadeh A; Shah SA
    Liver Transpl; 2011 Oct; 17(10):1191-9. PubMed ID: 21604357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation by center and economic burden of readmissions after liver transplantation.
    Wilson GC; Hoehn RS; Ertel AE; Wima K; Quillin RC; Hohmann S; Paterno F; Abbott DE; Shah SA
    Liver Transpl; 2015 Jul; 21(7):953-60. PubMed ID: 25772696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of the utilization of liver allografts with high donor risk index.
    Axelrod DA; Schnitzler M; Salvalaggio PR; Swindle J; Abecassis MM
    Am J Transplant; 2007 Apr; 7(4):990-7. PubMed ID: 17391139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Elderly Allografts in Liver Transplantation.
    Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
    Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital Resource Use with Donation after Cardiac Death Allografts in Liver Transplantation: A Matched Controlled Analysis from 2007 to 2011.
    Singhal A; Wima K; Hoehn RS; Quillin RC; Woodle ES; Paquette IM; Paterno F; Abbott DE; Shah SA
    J Am Coll Surg; 2015 May; 220(5):951-8. PubMed ID: 25840540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
    Foxton MR; Al-Freah MA; Portal AJ; Sizer E; Bernal W; Auzinger G; Rela M; Wendon JA; Heaton ND; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 May; 16(5):668-77. PubMed ID: 20440776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis.
    Wilson GC; Quillin RC; Wima K; Sutton JM; Hoehn RS; Hanseman DJ; Paquette IM; Paterno F; Woodle ES; Abbott DE; Shah SA
    HPB (Oxford); 2014 Dec; 16(12):1088-94. PubMed ID: 25099347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.
    Blok JJ; Braat AE; Adam R; Burroughs AK; Putter H; Kooreman NG; Rahmel AO; Porte RJ; Rogiers X; Ringers J; ;
    Liver Transpl; 2012 Jan; 18(1):112-9. PubMed ID: 21987454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donation after cardiac death liver transplantation is associated with increased risk of end-stage renal disease.
    Ruebner RL; Reese PP; Abt PL
    Transpl Int; 2014 Dec; 27(12):1263-71. PubMed ID: 25070497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The donor risk index: A decade of experience.
    Flores A; Asrani SK
    Liver Transpl; 2017 Sep; 23(9):1216-1225. PubMed ID: 28590542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal outcomes after liver transplantation in the model for end-stage liver disease era.
    Sharma P; Welch K; Eikstadt R; Marrero JA; Fontana RJ; Lok AS
    Liver Transpl; 2009 Sep; 15(9):1142-8. PubMed ID: 19718633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.
    Haugen CE; Holscher CM; Luo X; Bowring MG; Orandi BJ; Thomas AG; Garonzik-Wang J; Massie AB; Philosophe B; McAdams-DeMarco M; Segev DL
    JAMA Surg; 2019 May; 154(5):441-449. PubMed ID: 30758494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15.
    Brown S; Savva Y; Barth R; LaMattina J; Thuluvath PJ
    Transplantation; 2020 Apr; 104(4):762-769. PubMed ID: 31568393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.